Abstract
There is an emerging trend in microRNA research and thus substantial progress in microRNA technologies. In this chapter we provide insights into the main microRNA specific methodologies and critical steps of microRNA expression profiling, target gene identification, and functional confirmation of microRNA effects up to in vivo application of antagomirs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amaral PP, Dinger ME, Mercer TR et al (2008) The eukaryotic genome as an RNA machine. Science 319:1787–1789
Huntzinger E, Izaurralde E (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12:99–110
Jackson RJ, Standart N (2007) How do microRNAs regulate gene expression? Sci STKE 2007:re1.
Sayed D, Abdellatif M (2011) MicroRNAs in development and disease. Physiol Rev 91: 827–887
D'Haene B, Mestdagh P, Hellemans J et al (2012) miRNA expression profiling: from reference genes to global mean normalization. Methods Mol Biol 822:261–272
Dweep H, Sticht C, Pandey P et al (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44: 839–847
Papadopoulos GL, Alexiou P, Maragkakis M et al (2009) DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 25:1991–1993
Krutzfeldt J, Rajewsky N, Braich R et al (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438:685–689
Mattes J, Collison A, Plank M et al (2009) Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A 106:18704–18709
Collison A, Mattes J, Plank M et al (2011) Inhibition of house dust mite-induced allergic airways disease by antagonism of micro RNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol 128:160.e4–167.e4
Pandit KV, Corcoran D, Yousef H et al (2010) Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182:220–229
Stenvang J, Kauppinen S (2008) MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther 8:59–81
Wang B, Howel P, Bruheim S et al (2011) Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One 6:e17167
Git A, Dvinge H, Salmon-Divon M et al (2010) Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16: 991–1006
Sato F, Tsuchiya S, Terasawa K et al (2009) Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One 4:e5540
Mestdagh P, Van Vlierberghe P, De Weer A et al (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10:R64
Li L, Xu J, Yang D et al (2010) Computational approaches for microRNA studies: a review. Mamm Genome 21:1–12
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Kaeuferle, T., Bartel, S., Dehmel, S., Krauss-Etschmann, S. (2014). MicroRNA Methodology: Advances in miRNA Technologies. In: Anders, HJ., Migliorini, A. (eds) Innate DNA and RNA Recognition. Methods in Molecular Biology, vol 1169. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0882-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0882-0_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0881-3
Online ISBN: 978-1-4939-0882-0
eBook Packages: Springer Protocols